Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eidos Therapeutics Inc.

Division of BridgeBio Pharma Inc.
http://eidostx.com

Latest From Eidos Therapeutics Inc.

After IPO, BridgeBio Looks To Tuck Eidos Back Into Its Flock

Is Eidos a goose that could lay a golden egg? BridgeBio wants to own it all, instead of two-thirds, in case its subsidiary's lead program in TTR amyloidosis succeeds in Phase III.

Deals M & A

Pharma Intelligence Congratulates The CARE Awards Winners

The fourth annual CARE Awards returned to Boston, Massachusetts, 2 May to once again recognize and commend key achievements across the spectrum of drug development that took place in 2018.
Clinical Trials Innovation

Pharma Intelligence Congratulates The CARE Awards Winners

The fourth annual CARE Awards returned to Boston, Massachusetts, 2 May to once again recognize and commend key achievements across the spectrum of drug development that took place in 2018.
Clinical Trials Innovation

BridgeBio’s $299m Gives It Two More Years Of Runway To Launch New Companies

The company emerged in 2017 with $135m to spin out rare genetic disease-focused subsidiaries. Now with 18 start-ups and two near-term filings for drug approvals, BridgeBio will fund existing programs as they progress and continue to buy new assets.

Financing Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • BridgeBio Pharma Inc.
  • Senior Management
  • Neil Kumar, PhD, CEO
    Christine Siu, CFO
    Jonathan Fox, MD, PhD, President & CMO
    Uma Sinha, PhD, CSO
  • Contact Info
  • Eidos Therapeutics Inc.
    Phone: (415) 887-1471
    101 Montgomery St
    Suite 2550
    San Francisco, CA 94101
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register